Seminar Series 2011

Our seminars are usually held on the first Thursday of each month.

The meeting is held at noon in Room C1-7 of the Communicore (room may be subject to change).

January 6th
Lilach Lerman, MD, PhD
Professor of Medicine, Mayo Medical School and Mayo Graduate School of Medicine
Associate Chair for Research, Division of Nephrology and Hypertension
“Cell-based Therapy in Experimental Renovascular Disease”
February 3rd
Debra Diz, PhD
Interim Director, Hypertension and Vascular Research Center 
Wake Forest University Baptist Medical Center, Winston Salem, NC
“Baroreflex Dysfunction in Aging and Hypertension”
March 3rd
Ariel Gomez, MD
Harrison Distinguished Professor of Pediatrics and Biology at the University of Virginia
“Regulation of Renin Cell Identity and Homeostasis”
April 7th
Richard L. Moss, PhD
Senior Associate Dean for Basic Research, Biotechnology and Graduate Studies
University of Florida
“Myosin Binding Protein-C: A Key Mediator of α-Adrenergic Stimulation of Cardiac Contractility in Health and Disease”
May 5th
Douglas Eaton, PhD
Distinguished Professor and Chair of Physiology
Emory University Medical School, Atlanta, GA
“Epithelial Na Channel Trafficking: Some Assembly Required”
June 2nd
Leopoldo Raij, MD
Director, Program for International Research Scholars
University of Miami, Miller School of Medicine, International Medicine Institute
“Salt Sensitivity of Hypertension: Are We Getting to the Bottom of the Salt Shaker?”
Summer Break  (no seminars)
September 1st
Nancy Rusch, PhD
Professor and Chair, Department of Pharmacology and Toxicology
University of Arkansas for Medical Sciences 
“Targeting of Calcium Channel Subunits as Antihypertensive Therapy”
September 29th
Alan Kim Johnson, PhD
F. Wendell Miller Distinguished Professor of Psychology and Pharmacology
University of Iowa
“The Psychobiology of Salt Hunger and Salt Gluttony”
November 3rd
Nadar Abraham, PhD
Professor and Chair, Department of Physiology and Pharmacology at the University of Toledo Health Science Campus
“Stem Cells Defects in Metabolic Syndrome and CVD: Role of Heme Oxygenase and Adiponectin in Insulin Resistance”
November 17th
Thomas Unger, MD, PhD
Chair of Pharmacology and Director of the Institute of Pharmacology
Charité – Universitätsmedizin Berlin
“Cardiovascular Drug Development in Academia: Chances and Pitfalls”
December 8th
Douglas Marchuk, PhD
Professor and Vice Chair, Department of Molecular Genetics and Microbiology
Duke University Medical Center
“Natural Sequence Variation Regulates Cerebral Infarction Volume”